Enhanced Antimalarial and Antisequestration Activity of Methoxybenzenesulfonate-Modified Biopolymers and Nanoparticles for Tackling Severe Malaria.

Authors:
Najer A; Kim J; Saunders C; Che J; Baum J and 1 more

Journal:
ACS Infect Dis

Publication Year: 2024

DOI:
10.1021/acsinfecdis.3c00564

PMCID:
PMC10862538

PMID:
38271991

Journal Information

Full Title: ACS Infect Dis

Abbreviation: ACS Infect Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Anti-Infective Agents

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"The authors declare the following competing financial interest(s): M.M.S. has filed a patent application (1810010.7) and has a registered trademark (US Reg. No. 6088213) covering the name SPARTA and the techniques described in the manuscript by Penders et al. (https://doi.org/10.1038/s41467-018-06397-6). M.M.S. is a founder of SPARTA Biodiscovery Ltd. C.S. is a current employee at SPARTA Biodiscovery Ltd."

Evidence found in paper:

"The authors kindly acknowledge Dr Akemi Nogiwa Valdez for editing of the manuscript and data management support. Prof. Alister Craig and Dr Janet Storm at LSTM are thanked for kindly providing the ItG parasite line. A.N. acknowledges support from a Sir Henry Wellcome Postdoctoral Fellowship (209121_Z_17_Z) from the Wellcome Trust. J.K. acknowledges the support of the National Research Foundation (NRF) grant (2022R1A6A3A03069072) funded by the Korean Government. C.S. acknowledges funding from EPSRC Centre for Doctoral Training in the Advanced Characterisation of Materials (EP/S023259/1). J.C. acknowledges support from the China Scholarship Council. J.B. was supported by an Investigator Award from Wellcome (100993/Z/13/Z). A.N. and M.M.S. acknowledge support from the EPSRC IRC Agile Early Warning Sensing Systems for Infectious Diseases and Antimicrobial Resistance (EP/R00529X/1) and the Imperial College and LKC School of Medicine Collaborative Fund. M.M.S. acknowledges support from the Royal Academy of Engineering Chair in Emerging Technologies award (CiET2021\94) and from the Rosetrees Trust. The authors thank the Light Microscopy Facilities at the Francis Crick Institute (London, UK) for access to FCS. This research was funded in part by the Wellcome Trust (209121_Z_17_Z to A.N. and 100993/Z/13/Z to J.B.). For the purpose of open access, the author has applied a CC-BY public copyright license to any Author Accepted Manuscript version arising from this submission. Raw data is available upon request from rdm-enquiries@imperial.ac.uk."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025